Nom du produit:4-Chloro-3-cyclopropyl-1H-pyrazolo[4,3-c]pyridine

IUPAC Name:4-chloro-3-cyclopropyl-1H-pyrazolo[4,3-c]pyridine

CAS:1246350-02-6
Formule moléculaire:C9H8ClN3
Pureté:95%+
Numéro de catalogue:CM270654
Poids moléculaire:193.63

Unité d'emballage Stock disponible Prix($) Quantité
CM270654-1g 1-2 Weeks ƅǺň

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1246350-02-6
Formule moléculaire:C9H8ClN3
Point de fusion:-
Code SMILES:ClC1=NC=CC2=C1C(C3CC3)=NN2
Densité:
Numéro de catalogue:CM270654
Poids moléculaire:193.63
Point d'ébullition:
N° Mdl:MFCD28405414
Stockage:

Category Infos

Pyrazolopyridines
Over the past few years, many pyrazole fused-ring systems, especially with applications in medicinal chemistry, have been published. These include general structures such as pyrazoline, pyrazoline, pyrazoquinoline, pyrazoloisoquinoline, pyrazoline, pyrazolopyrazine, pyrazolopyrazine, pyranopyrazole, pyrano Pyrazoles, pyrazolotriazines and pyrazole fused phosphorus rings.
Cyclopropanes
Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.